Do you want to read an article? Please log in or register.
New approach for detection of LDL-hypercholesterolemia in the pediatric population: The Fr1dolin-Trial in Lower Saxony, German
Lipids
Related content
COMMENTED
Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
★ 2
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol.
Wang N, Fulcher J, Abeysuriya N, Park L, Kumar S, Di Tanna GL, Wilcox I, Keech A, Rodgers A, Lal S
doi: 10.1016/S2213-8587(19)30388-2.
Lipids
Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk
High Blood Press Cardiovasc Prev.
Agabiti Rosei E, Salvetti M
doi: 10.1007/s40292-016-0155-2
RECOMMENDED
Lipids
Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial
Diabetes Care.
Leiter LA, Teoh H, Kallend D, Wright RS, Landmesser U, Wijngaard PLJ, Kastelein JJP, Ray KK
doi: 10.2337/dc18-1491.
Effect of lipid-lowering treatment in cardiovascular disease prevalence in familial hypercholesterolemia
Atherosclerosis.
Perez-Calahorra S, Laclaustra M, Marco-Benedí V, Lamiquiz-Moneo I, Pedro-Botet J, Plana N, Sanchez-Hernandez RM, Amor AJ, Almagro F, Fuentes F, Suarez-Tembra M, Civeira F; Dyslipemia Registry of Spanish Arteriosclerosis Society
doi: 10.1016/j.atherosclerosis.
COMMENTED
Lipids
How to identify familial premature myocardial infarction: comparing approaches to identify familial hypercholesterolemia
J Clin Endocrinol Metab.
Beheshti S, Madsen CM, Varbo A, Nordestgaard BG
doi: 10.1210/jc.2018-02261.
COMMENTED
Diabetes - General
Effect of PCSK9 Inhibitors on Clinical Outcomes in Patients With Hypercholesterolemia: A Meta-Analysis of 35 Randomized Controlled Trials
J Am Heart Assoc.
Karatasakis A, Danek BA, Karacsonyi J, Rangan BV, Roesle MK, Knickelbine T, Miedema MD, Khalili H, Ahmad Z, Abdullah S, Banerjee S, Brilakis ES
doi: 10.1161/JAHA.117.006910.
Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials
Int J Cardiol.
Farnier M, Gaudet D, Valcheva V, Minini P, Miller K, Cariou B
doi: 10.1016/j.ijcard.2016.08.273.
COMMENTED
Diabetes - GeneralType 2 Diabetes
Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults
Diabetologia.
Simmons RK, Griffin SJ, Witte DR, Borch-Johnsen K, Lauritzen T, Sandbæk A
doi: 10.1007/s00125-017-4323-2.
Evidence for more intensive cholesterol lowering
Curr Opin Lipidol.
Soran H, Kwok S, Adam S, Ho JH, Durrington PN
doi: 10.1097/